Literature DB >> 27532900

Regioselective Amine-Borane Cyclization: Towards the Synthesis of 1,2-BN-3-Cyclohexene by Copper-Assisted Triazole/Gold Catalysis.

Stephen E Motika1, Qiaoyi Wang2, Novruz G Akhmedov2, Lukasz Wojtas1, Xiaodong Shi3.   

Abstract

The combination of triazole/gold (TA-Au) and Cu(OTf)2 is identified as the optimal catalytic system for promoting intramolecular hydroboration for the synthesis of a six-membered cyclic amine-borane. Excellent yields (up to 95 %) and regioselectivities (5-exo vs. 6-endo) were achieved through catalyst control and sequential dilution. Good functional-group tolerance was attained, thus allowing the preparation of highly functionalized cyclic amine-borane substrates, which could not be achieved using other methods. Deuterium-labeling studies support the involvement of a hydride addition to a gold-activated alkyne with subsequent C-B bond formation.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  boranes; copper; gold; heterocycles; reaction mechanisms

Year:  2016        PMID: 27532900     DOI: 10.1002/anie.201604986

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  3 in total

1.  Accessing alternative reaction pathways of the intermolecular condensation between homo-propargyl alcohols and terminal alkynes through divergent gold catalysis.

Authors:  Courtney A Smith; Stephen E Motika; Lukasz Wojtas; Xiaodong Shi
Journal:  Chem Commun (Camb)       Date:  2017-02-16       Impact factor: 6.222

2.  Design and synthesis of stable four-coordinated benzotriazole-borane with tunable fluorescence emission.

Authors:  Qi Tang; Shi-Jun Li; Xiaohan Ye; Teng Yuan; Kai Zhao; Ying He; Chuan Shan; Lukasz Wojtas; David Richardson; Yu Lan; Xiaodong Shi
Journal:  Chem Sci       Date:  2022-04-18       Impact factor: 9.969

3.  Synthesis and application of a novel bis-1,2,3-triazole ligand containing a 2,2'-bipyrrolidine core.

Authors:  Stephen E Motika; Xiaodong Shi
Journal:  ARKIVOC       Date:  2018-01-28       Impact factor: 1.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.